1. Home
  2. CTSO vs NTIC Comparison

CTSO vs NTIC Comparison

Compare CTSO & NTIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • NTIC
  • Stock Information
  • Founded
  • CTSO 1997
  • NTIC 1970
  • Country
  • CTSO United States
  • NTIC United States
  • Employees
  • CTSO N/A
  • NTIC N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • NTIC Industrial Specialties
  • Sector
  • CTSO Health Care
  • NTIC Industrials
  • Exchange
  • CTSO Nasdaq
  • NTIC Nasdaq
  • Market Cap
  • CTSO 65.7M
  • NTIC 75.2M
  • IPO Year
  • CTSO N/A
  • NTIC N/A
  • Fundamental
  • Price
  • CTSO $0.95
  • NTIC $7.52
  • Analyst Decision
  • CTSO Buy
  • NTIC
  • Analyst Count
  • CTSO 2
  • NTIC 0
  • Target Price
  • CTSO $5.50
  • NTIC N/A
  • AVG Volume (30 Days)
  • CTSO 93.3K
  • NTIC 32.0K
  • Earning Date
  • CTSO 08-07-2025
  • NTIC 07-10-2025
  • Dividend Yield
  • CTSO N/A
  • NTIC 0.52%
  • EPS Growth
  • CTSO N/A
  • NTIC N/A
  • EPS
  • CTSO N/A
  • NTIC 0.31
  • Revenue
  • CTSO $35,332,238.00
  • NTIC $85,268,129.00
  • Revenue This Year
  • CTSO $11.15
  • NTIC $1.09
  • Revenue Next Year
  • CTSO $21.39
  • NTIC $5.69
  • P/E Ratio
  • CTSO N/A
  • NTIC $24.88
  • Revenue Growth
  • CTSO 15.37
  • NTIC 3.46
  • 52 Week Low
  • CTSO $0.71
  • NTIC $6.75
  • 52 Week High
  • CTSO $1.61
  • NTIC $15.09
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 39.94
  • NTIC 45.33
  • Support Level
  • CTSO $0.91
  • NTIC $7.72
  • Resistance Level
  • CTSO $1.06
  • NTIC $8.15
  • Average True Range (ATR)
  • CTSO 0.06
  • NTIC 0.29
  • MACD
  • CTSO -0.01
  • NTIC -0.07
  • Stochastic Oscillator
  • CTSO 13.97
  • NTIC 0.00

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About NTIC Northern Technologies International Corporation

Northern Technologies International Corp, or NTIC is a United States-based firm that develops and markets environmentally beneficial products and services world-wide either directly or through a network of joint ventures, distributors, and agents. It operates through two segments which include ZERUST products and services and Nature-Tec products. Its main business is providing corrosion prevention solutions that are marketed under the ZERUST brand. The company also sells a portfolio of bio-based and biodegradable (compostable) polymer resin compounds and finished products marketed under the Nature-Tec brand. The ZERUST brand generates a vast majority of the revenue for the company.

Share on Social Networks: